Skip to search formSkip to main contentSkip to account menu

FR 110302

Known as: 1-Naphthalenol, 2,2-dibutyl-1,2,3,4-tetrahydro-5-(2-quinolinylmethoxy)-, FR-110302, FR110302 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

NaphtholsQuinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs
Airway hyperresponsiveness is a key feature of asthma, and attenuating airway hyperresponsiveness is an important part of asthma… 
1998
1998
Studies on 5-lipoxygenase inhibitors. II. Discovery, optical resolution and enantioselective synthesis of FR110302, a highly potent non-redox type 5-lipoxygenase inhibitor.
A novel series of 2,2-dialkyl-5-(2-quinolylmethoxy)-1,2,3, 4-tetrahydro-1-naphthols was synthesized and evaluated as 5… 
Review
1997
Review
1997
Biosynthesis inhibitors for leukotrienes in bronchial asthma.
This article reviews the literature on the effects of leukotrienes in asthma. In particular, the ability of recently developed… 
1991
1991
Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)